Solventum (SOLV) Cash & Equivalents (2023 - 2026)

Solventum (SOLV) has 4 years of Cash & Equivalents data on file, last reported at $561.0 million in Q1 2026.

• Quarterly Cash & Equivalents rose 5.06% year-over-year to $561.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $561.0 million (up 5.06% YoY) and the FY2025 annual result came in at $878.0 million, up 15.22% from the prior year.
• Cash & Equivalents declined to $561.0 million in Q1 2026, from $878.0 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $1.6 billion in Q3 2025 to a low of $194.0 million in Q4 2023.
• A 4-year average of $772.8 million and a median of $767.0 million in 2024 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2024 — Cash & Equivalents surged 292.78% — and 2025, when it tumbled 46.39%.
• Tracing SOLV's Cash & Equivalents over 4 years: stood at $194.0 million in 2023, then surged by 292.78% to $762.0 million in 2024, then gained by 15.22% to $878.0 million in 2025, then plunged by 36.1% to $561.0 million in 2026.
• The last three Cash & Equivalents figures came in at $561.0 million (Q1 2026), $878.0 million (Q4 2025), and $1.6 billion (Q3 2025), per Business Quant data.